$120.53
0.00130%
Last update: Oct 30, 4:00 PM
ProShares Ultra Nasdaq Biotechnology (BIB) Stock Price, Quote, News & History
BIBNASDAQ
Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: CMPS) revealed Friday that it has been selected for addition to the Nasdaq...
You can purchase shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) through any online brokerage.
There are no as such competitors for ProShares Ultra Nasdaq Biotechnology.
There is no analysis for ProShares Ultra Nasdaq Biotechnology to provide a consensus price target.
The stock price for ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB) is $121.3 last updated October 29, 2026 at 9:21 AM EDT.
There are no upcoming dividends for ProShares Ultra Nasdaq Biotechnology.
ProShares Ultra Nasdaq Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for ProShares Ultra Nasdaq Biotechnology.
The Fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. Majority of stocks in this equity fund have average financial performance and low growth...
